1 result
  • caplyta

    (lumateperone)
    Intra-Cellular Therapies, Inc
    CAPLYTA is indicated for treating schizophrenia in adults and for depressive episodes associated with bipolar I or II disorder in adults, both as monotherapy and as adjunctive therapy with lithium or valproate.